Comparative Study of Intermittent Catheters and Occurrence of Urinary Tract Infections
- Full Text View
- Tabular View
- Study Results
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of this study is to investigate the frequency of urinary tract infections with symptoms in spinal cord injured patients requiring intermittent catheterization for emptying the bladder. Patients will use either a coated catheter or an uncoated catheter with gel.
| Condition | Intervention | Phase |
|---|---|---|
|
Urinary Tract Infections |
Device: SpeediCath Device: Conveen Uncoated |
Phase 4 |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Open Label Primary Purpose: Prevention |
| Official Title: | A Prospective, Randomized, Parallel-group, Multi-center Study to Compare the Occurrence of Urinary Tract Infections in Patients With Spinal Cord Injury Using Either Coated or Uncoated Intermittent Catheters. |
- Occurrence of Symptomatic Urinary Tract Infections (UTIs) [ Time Frame: 4-6 months ] [ Designated as safety issue: Yes ]Occurrence of symptomatic urinary tract infections (UTIs). Time to first UTI
- UTIs With Bacteriuria >=100 Colony Forming Units (CFU)/ml [ Time Frame: 4-6 months ] [ Designated as safety issue: Yes ]UTIs with bacteriuria >=100 Colony Forming Units (CFU)/ml. Descriptive analysis
- Nurse Evaluation of Catheters - Overall Satisfaction [ Time Frame: 4-6 months ] [ Designated as safety issue: No ]Evaluation score on an 11-point scale from 0-10 (0 being lowest satisfaction)
- Patient or Caregiver's Evaluation of Catheters - Overall Satisfaction [ Time Frame: 4-6 months ] [ Designated as safety issue: No ]Evaluation score on an 11-point scale from 0-10 (0 being lowest satisfaction)
- Nurse Time Spent on Catheterization Procedure [ Time Frame: 4-6 months ] [ Designated as safety issue: No ]
- Health Economic Measures [ Time Frame: 4-6 months ] [ Designated as safety issue: No ]
- Device-related or Possibly Device-related AEs [ Time Frame: 4-6 months ] [ Designated as safety issue: Yes ]
- Number of Participants With One or More Urinary Tract Infection [ Time Frame: 4-6 months ] [ Designated as safety issue: Yes ]
| Enrollment: | 219 |
| Study Start Date: | April 2006 |
| Study Completion Date: | October 2009 |
| Primary Completion Date: | October 2009 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: SpeediCath
hydrophilic-coated intermittent catheter
|
Device: SpeediCath
hydrophilic coated urinary intermittent catheter
Other Name: Coated Catheter
|
|
Experimental: Conveen Uncoated
uncoated urinary intermittent catheter
|
Device: Conveen Uncoated
Uncoated urinary intermittent catheter
Other Name: Uncoated catheter
|
Detailed Description:
Introduction:
Spinal cord injured (SCI) constitutes a large group of patients suffering from neurogenic bladder dysfunction, which is often managed by intermittent catheterization (IC). Intermittent catheterization is accepted as a safe and effective method for maintaining bladder and renal health in individuals with neurogenic bladder dysfunction. However, IC several times a day places an individual at risk for urethral trauma, hematuria, and particularly symptomatic urinary tract infections (UTI).
Attempts to control UTI with prophylactic antibiotics or sterile technique have not been overly successful but more recent advances in catheter technology, such as the hydrophilic-coated catheter, offer potential benefit. The hydrophilic-coated catheter has a slippery, pre-lubricated surface (along the entire length of the catheter) when soaked in water, allowing smooth insertion without the need for additional water soluble lubricant. Two proposed advantages over uncoated catheters are 1) reduced incidence of symptomatic UTI, and 2) reduction of urethral irritation or urethral trauma, and lowered risk of urethral strictures. Currently, while there are trends in favour of hydrophilic-coated catheters with respect to UTI overall evidence remains inadequate for clinical decision-making for choice of catheter type. Randomised trials to date have been limited by short follow up, heterogeneity, attrition, imprecise outcome measures, and varying definitions of UTI5. Conclusions of the Cochrane group in 20076 were echoed in a recent comprehensive re-view of all studies on hydrophilic-coated catheters - there is modest evidence favouring hydrophilic-coated catheter in reduction of UTI, but further robust research is required.
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Traumatic spinal cord injury within 3 months prior to inclusion
- Neurogenic bladder dysfunction requiring intermittent catheterization at least 3 times daily
Exclusion Criteria:
- Has symptoms of UTI at inclusion
- Treated with prophylactic antibiotics to prevent UTIs
- Has a history of unresolved bladder-ureteral reflux and/or stones in the urinary tract
- Has used intermittent catheterization for more than 10 days prior to inclusion
Contacts and Locations| United States, California | |
| Rancho Los Amigos National Rehabilitation Center | |
| Downey, California, United States, 90242 | |
| Santa Clara Valley Medical Center | |
| San Jose, California, United States, 95128 | |
| United States, Colorado | |
| Craig Hospital | |
| Englewood, Colorado, United States, 80113 | |
| United States, Florida | |
| University of Miami | |
| Miami, Florida, United States, 33101 | |
| United States, Georgia | |
| Shepherd Center | |
| Atlanta, Georgia, United States, 30309 | |
| United States, Massachusetts | |
| Boston Medical School | |
| Boston, Massachusetts, United States, 02188 | |
| United States, Michigan | |
| University of Michigan Helaths Systems | |
| Ann Arbor, Michigan, United States, 48108 | |
| United States, Minnesota | |
| Mayo Clinic, Saint Mary Hospital MB3CF Rehabilitation | |
| Rochester, Minnesota, United States, 55902 | |
| United States, New Jersey | |
| Kessler Institute for Rehabilitation | |
| West Orange, New Jersey, United States, 07052 | |
| United States, New York | |
| Mount Sinai School of Medicine | |
| New York, New York, United States, 10029 | |
| United States, North Carolina | |
| Carolinas Medical Center | |
| Charlotte, North Carolina, United States, 28303 | |
| United States, Texas | |
| The Institute for Rehabilitation and Research (TIRR) | |
| Houston, Texas, United States, 77030 | |
| Canada, Alberta | |
| University of Alberta | |
| Edmonton, Alberta, Canada, T6G 2C8 | |
| Canada, British Columbia | |
| G.F.Strong Rehabilitation Centre | |
| Vancouver, British Columbia, Canada, V5Z 2G9 | |
| Canada, Ontario | |
| Parkwood Rehabilitation Centre | |
| London, Ontario, Canada, N6A 4G5 | |
| Toronto Rehabilitation Centre | |
| Toronto, Ontario, Canada, M4G 3V9 | |
| Principal Investigator: | Diana Cardenas, MD | University of Miami |
More Information
No publications provided
| Responsible Party: | Coloplast A/S |
| ClinicalTrials.gov Identifier: | NCT00318591 History of Changes |
| Other Study ID Numbers: | DK046CC |
| Study First Received: | April 26, 2006 |
| Results First Received: | February 23, 2011 |
| Last Updated: | October 4, 2011 |
| Health Authority: | United States: Institutional Review Board Canada: Ethics Review Committee |
Additional relevant MeSH terms:
|
Spinal Cord Injuries Urinary Tract Infections Spinal Cord Diseases Central Nervous System Diseases Nervous System Diseases |
Trauma, Nervous System Wounds and Injuries Infection Urologic Diseases |
ClinicalTrials.gov processed this record on May 23, 2013